Effects of interleukin-1β and tumor necrosis factor-α on macrophage inflammatory protein-3α production in synovial fibroblast-like cells from human temporomandibular joints

Journal of Oral Pathology and Medicine

Volumn 42, Issue 6, 2013, Pages 491-498

  Akutsu, Miwa ^a   Ogura, Naomi ^a   Ito, Ko ^a   Kawashima, Mutsumi ^a   Kishida, Tsuyoshi ^a   Kondoh, Toshirou ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Interleukin 1 ; Macrophage inflammatory protein 3 ; Synovial fibroblast like cell; Temporomandibular joint; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; OLIGONUCLEOTIDE; RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SYNOVIUM; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; UPREGULATION;

INTERLEUKIN-1Β; MACROPHAGE INFLAMMATORY PROTEIN-3Α; SYNOVIAL FIBROBLAST-LIKE CELL; TEMPOROMANDIBULAR JOINT; TUMOR NECROSIS FACTOR-Α;

ADOLESCENT; ADULT; ANTHRACENES; CELL CULTURE TECHNIQUES; CHEMOKINE CCL20; DISLOCATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLASTS; FLAVONOIDS; GENE EXPRESSION PROFILING; HUMANS; IMIDAZOLES; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRIDINES; SYNOVIAL MEMBRANE; TEMPOROMANDIBULAR JOINT DISORDERS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84879888546     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12040     Document Type: Article

References (46)

1. Dijkgraaf LC, Liem RSB, de Bont LGM. Synovial membrane involvement in osteoarthritic temporomandibular joints. A light microscopic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 373-86.
2. Kondoh T, Dolwick MF, Hamada Y, Seto K. Visually guided irrigation for patients with symptomatic internal derangement of the temporomandibular joint: a preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 544-51.
3. Gynther GW, Holmlund AB, Reinholt FP, Lindblad S. Temporomandibular joint involvement in generalized osteoarthritis and rheumatoid arthritis: a clinical, arthroscopic, histologic, and immunohistochemical study. Int J Oral Maxillofac Surg 1997; 26: 10-6.
4. Gynther GW, Dijkgraaf LC, Reinholt FP, Holmlund AB, Liem RSB, de Bont LGM. Synovial inflammation in arthroscopically obtained biopsy specimens from the temporomandibular joint: a review of the literature and a proposed histologic grading system. J Oral Maxillofac Surg 1998; 56: 1281-6.
5. Kardel R, Ulfgren A-K, Reinholt FP, Holmlund A. Inflammatory cell and cytokine patterns in patients with painful clicking and osteoarthritis in the temporomandibular joint. Int J Oral Maxillofac Surg 2003; 32: 390-6.
6. Richards CD, Agro A. Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblasts. Cytokine 1994; 6: 40-7.
7. Ogura N, Akutsu M, Tobe M, Sakamaki H, Abiko Y, Kondoh T. Microarray analysis of IL-1β-stimulated chemokine genes in synovial fibroblasts from human TMJ. J Oral Pathol Med 2007; 36: 223-8.
8. Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology 2004; 43: iii2-9.
9. Manicourt D-H, Poilvache P, van Egeren A, Devogelaer J-P, Lenz M-E, Thonar EJMA. Synovial fluid levels of tumor necrosis factor α and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 2000; 43: 281-8.
10. Field M. Tumour necrosis factor polymorphisms in rheumatic diseases. Q J Med 2001; 94: 237-46.
11. Suzuki T, Segami N, Nishimura M, Nojima T. Co-expression of interleukin-1β and tumor necrosis factor α in synovial tissues and synovial fluids of temporomandibular joint with internal derangement: comparision with histological grading of synovial inflammation. J Oral Pathol Med 2002; 31: 549-57.
12. Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 135-41.
13. Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg 2002; 40: 418-23.
14. Gulen H, Ataoglu H, Haliloglu S, Isik K. Proinflammatory cytokines in temporomandibular joint synovial fluid before and after arthrocentesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: e1-4.
15. Rossi DL, Vicari AP, Franz-Bacon K, McClanahan TK, Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines MIP-3α and MIP-3β. J Immunol 1997; 158: 1033-6.
16. Gale LM, McColl SR. Chemokines: extracelular messengers for all occasions? BioEssays 1999; 21: 17-28.
17. Ruth JH, Shahrara S, Park CC, et al. Role of macrophage inflammatory protein-3α and its ligand CCR6 in rheumatoid arthritis. Lab Invest 2003; 83: 579-88.
18. Ogura N, Tobe M, Sakamaki H, et al. Interleukin-1β induces interleukin-6 mRNA expression and protein production in synovial cells from human temporomandibular joint. J Oral Pathol Med 2002; 31: 353-60.
19. Tobe M, Ogura N, Abiko Y, Nagura H. Interleukin-1β stimulates interleukin-8 production and gene expression in synovial cells from human temporomandibular joint. J Oral Maxillofac Surg 2002; 60: 741-7.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
21. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 α. J Immunol 1999; 162: 186-94.
22. Sierro F, Dubois B, Coste A, Kaiserlian D, Kraehenbuhl J-P, Sirard J-C. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. PNAS 2001; 98: 13722-7.
23. Liao F, Shirakawa A-K, Foley JF, Rabin RL, Farber JM. Human B cells become highly responsive to macrophage-inflammatory protein-3α/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol 2002; 168: 4871-80.
24. Cavanagh LL, Boyce A, Smith L, et al. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther 2005; 7: R230-40.
25. Tran CN, Lundy SK, Fox DA. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 2005; 12: 183-9.
26. Reparon-Schuijt CC, van Esch WJE, van Kooten C, Levarht EWN, Breedveld FC, Verweij CL. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients. Arthritis Rheum 1998; 41: 2211-20.
27. Matsui T, Akahoshi T, Namai R, et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3α in rheumatoid arthritis. Clin Exp Immunol 2001; 125: 155-61.
28. Kwon JH, Keates S, Simeonidis S, Grall F, Libermann TA, Keates AC. ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3α gene expression in Caco-2 human colonic epithelial cells. J Biol Chem 2003; 278: 875-84.
29. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clin Exp Immunol 2005; 142: 285-91.
30. Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T. Airway epithelial cells release MIP-3α/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 2003; 28: 648-54.
31. Stamatovic SM, Keep RF, Mostarica-Stojkovic M, Andjelkovic AV. CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol 2006; 177: 2651-61.
32. Gee K, Angel JB, Mishra S, Blahoianu MA, Kumar A. IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J Immunol 2007; 178: 798-807.
33. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-57.
34. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 1995; 92: 7686-9.
35. Kumar S, Jiang MS, Adams JL, Lee JC. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 1999; 263: 825-31.
36. Bogoyevitch MA, Arthur PG. Inhibitors of c-jun N-terminal kinases-JuNK no more? Biochim Biophys Acta 2008; 1784: 76-93.
37. Nakajima K, Matsushita Y, Tohyama Y, Kohsaka S, Kurihara T. Differential suppression of endotoxin-inducible inflammatory cytokines by nuclear factor kappa B (NFκB) inhibitor in rat microglia. Neurosci Lett 2006; 401: 199-202.
38. Sato J, Segami N, Suzuki T, Kaneyama K, Yoshitake Y, Nishikawa K. The expression of vascular endothelial growth factor in synovial tissues in patients with internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 251-6.
39. van Lent PLEM, Figdor CG, Barrera P, et al. Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells. Arthritis Rheum 2003; 48: 360-9.
40. Remans PHJ, van Oosterhout M, Smeets TJM, et al. Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 2005; 52: 2003-9.
41. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007; 213: 626-34.
42. Keren Z, Braun-Moscovici Y, Markovits D, et al. Depletion of B lymphocytes in rheumatoid arthritis patients modifies IL-8-anti-IL-8 autoantibody network. Clin Immunol 2009; 133: 108-16.
43. Lebre MC, Vergunst CE, Choi ILY, et al. Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis. PLoS ONE 2011; 6: e21772.
44. Inoue T, Yamashita M, Higaki M. The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1β-stimulated synoviocytes of patients with rheumatoid arthritis. Rheumatol Int 2001; 20: 149-53.
45. Ahmed S, Pakozdi A, Koch AE. Regulation of interleukin-1β-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2006; 54: 2393-401.
46. Randolph CS, Greene CS, Moretti R, Forbes D, Perry HT. Conservative management of temporomandibular disorders: A posttreatment comparison between patients from a university clinic and from private practice. Am J Orthod Dentofac Orthop 1990; 98: 77-82.